Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05089643. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical Trial
ClinicalTrials.gov study NCT05390476. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study
ClinicalTrials.gov study NCT06409221. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05475678. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)
ClinicalTrials.gov study NCT06225505. IPD Sharing: YES. Countries: 1. Publications: 0.
TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT03720431. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors
ClinicalTrials.gov study NCT05339685. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical Study
ClinicalTrials.gov study NCT06125080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06931769. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)
ClinicalTrials.gov study NCT05215106. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03464942. IPD Sharing: NO. Countries: 1. Publications: 0.
EvoLution of Neoadjuvant TreatMent in 'Triple-negative' or 'HER-2-positive' Breast Cancer Diagnosed in the EaRly Phase
ClinicalTrials.gov study NCT06894173. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer
ClinicalTrials.gov study NCT00491816. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.
ClinicalTrials.gov study NCT06140576. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile
ClinicalTrials.gov study NCT04250818. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT07011654. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Capecitabine in Low Risk Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06787339. IPD Sharing: Not stated. Countries: 1. Publications: 0.
QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine
ClinicalTrials.gov study NCT03554109. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06318897. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT05552001. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.